EMAIL THIS PAGE TO A FRIEND

Cytotherapy

Cell type-dependent variation in paracrine potency determines therapeutic efficacy against neonatal hyperoxic lung injury.


PMID 25863963

Abstract

The aim of this study was to determine the optimal cell type for transplantation to protect against neonatal hyperoxic lung injury. To this end, the in vitro and in vivo therapeutic efficacies and paracrine potencies of human umbilical cord blood-derived mesenchymal stromal cells (HUMs), human adipose tissue-derived mesenchymal stromal cells (HAMs) and human umbilical cord blood mononuclear cells (HMNs) were compared. Hyperoxic injury was induced in vitro in A549 cells by challenge with H2O2. Alternatively, hyperoxic injury was induced in newborn Sprague-Dawley rats in vivo by exposure to hyperoxia (90% oxygen) for 14 days. HUMs, HAMs or HMNs (5 × 10(5) cells) were given intratracheally at postnatal day 5. Hyperoxia-induced increases in in vitro cell death and in vivo impaired alveolarization were significantly attenuated in both the HUM and HAM groups but not in the HMN group. Hyperoxia impaired angiogenesis, increased the cell death and pulmonary macrophages and elevated inflammatory cytokine levels. These effects were significantly decreased in the HUM group but not in the HAM or HMN groups. The levels of human vascular endothelial growth factor and hepatocyte growth factor produced by donor cells were highest in HUM group, followed by HAM group and then HMN group. HUMs exhibited the best therapeutic efficacy and paracrine potency than HAMs or HMNs in protecting against neonatal hyperoxic lung injury. These cell type-dependent variations in therapeutic efficacy might be associated or mediated with the paracrine potency of the transplanted donor cells.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

HPA012315
Anti-HLA-DQA1 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB1401177
Anti-HLA-DQA1 antibody produced in rabbit, purified immunoglobulin, buffered aqueous solution
PRS2511
Anti-NOD2 (ab1) antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
PRS2513
Anti-NOD2 (ab2) antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
SAB1409648
Anti-NOD2 antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
HPA041985
Anti-NOD2 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB1411251
Anti-NOD2 antibody produced in rabbit, purified immunoglobulin, buffered aqueous solution
RAB0212
Human HGF ELISA Kit, for serum, plasma, cell culture supernatant and urine
RAB0213
Human HGF ELISA Kit, for cell and tissue lysates
RAB0676 Human MET / Hepatocyte Growth Factor Receptor ELISA Kit
SAB1402223
Monoclonal Anti-HLA-DQA1 antibody produced in mouse, clone 1A3, purified immunoglobulin, buffered aqueous solution
RAB0214
Mouse HGF ELISA Kit, for serum, plasma and cell culture supernatant
RAB0215
Mouse HGF ELISA Kit, for cell and tissue lysates
RAB0356 Phospho-Met (pTyr1234) and pan-Met ELISA Kit, for detection of phospho-met (pTyr1234) and pan-met in human or mouse cell and tissue lysates
RAB0355 Phospho-Met (pTyr1234) ELISA Kit, for detection of phospho-met (pTyr1234) in human or mouse cell and tissue lysates
RAB0980 Phosphotyrosine MET / Hepatocyte Growth Factor Receptor ELISA Kit